Position in GSK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$28,906,275
+$2,379,975 QoQ
Shares Held
551,436
+14.7% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#56
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. GSK ranks #8 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
248,532 | $89,998,407 | |
| 2 | LLY |
ELI LILLY & Co
|
65,278 | $78,296,398 | |
| 3 | NVS |
Novartis AG
|
442,978 | $69,423,512 | |
| 4 | JNJ |
Johnson & Johnson
|
156,545 | $39,757,733 | |
| 5 | AZN |
Astrazeneca PLC
|
192,721 | $36,543,756 | |
| 6 | MRK |
Merck & Co., Inc.
|
252,444 | $32,439,054 | |
| 7 | ABBV |
AbbVie Inc.
|
123,655 | $31,116,544 | |
| 8 | GSK |
GSK plc
This page
|
551,436 | $28,906,275 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,906,275 | 551,436 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $26,526,300 | 480,636 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $21,227,650 | 432,864 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $15,686,933 | 363,460 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $10,651,353 | 277,379 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,947,722 | 101,903 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,541,539 | 75,149 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $809,219 | 19,795 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $321,359 | 8,347 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $172,851 | 4,032 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $95,688 | 2,582 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,510 | 152 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $214,517 | 6,019 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $258,702 | 7,271 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $78,748 | 2,241 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $310,133 | 10,538 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $411,999 | 9,650 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $288,726 | 6,758 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $185,729 | 4,294 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $136,189 | 3,634 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $321,973 | 8,244 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,573,603 | 44,954 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,275,710 | 173,874 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,181,139 | 167,432 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,362,246 | 159,029 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $5,373,401 | 144,592 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||